To evaluate the Clinical Progression Scale-Pediatrics (CPS-Ped) as a standardized outcome metric for assessing clinical improvement in infants hospitalized for RSV-related critical illness, highlighting its potential to enhance clinical outcomes.
Key Findings:
65% of infants showed clinical improvement by day 7 as defined by CPS-Ped, with statistical significance noted.
Factors associated with failure to improve included age <3 months, prematurity, underlying respiratory conditions, and invasive mechanical ventilation within 24 hours.
Interpretation:
The CPS-Ped score could serve as a clinically meaningful outcome metric for RSV clinical trials, potentially improving the assessment of treatment efficacy compared to traditional metrics like length of hospital stay, thereby enhancing clinical practice.
Limitations:
Only infants were analyzed, limiting generalizability; this affects the applicability of findings to older children.
Data collected during a single respiratory season may not reflect broader trends, which could influence the robustness of the findings.
Variability in PICU practices may affect score application, highlighting the need for standardized protocols.
Conclusion:
The CPS-Ped score represents a promising tool for evaluating RSV severity and treatment outcomes in pediatric populations, with potential for broader application in clinical trials, emphasizing its importance in future RSV research.
Invited narrative review supports early, interprofessional rehabilitation across the ICU recovery continuum while emphasizing heterogeneous evidence and inconsistent implementation worldwide.
